{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T20:21:54Z","timestamp":1785270114448,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T00:00:00Z","timestamp":1691452800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T00:00:00Z","timestamp":1691452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Antimicrob Resist Infect Control"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Ventriculoperitoneal (VP) shunt infections in adults represent a severe complication and make treatment more challenging. Therefore, drug susceptibility patterns are crucial for therapeutic decisions and infection control in neurosurgical centers. This 7-year retrospective study aimed to identify the bacteria responsible for adult VP shunt infections and determine their drug susceptibility patterns.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This single-center study was performed from 2015 to 2021 in Lahore, Pakistan, and included CSF cultures from VP shunt infections. Demographic data, causative organisms, and antimicrobial susceptibility testing results were collected. Multivariate analysis of variance (MANOVA) and two-sample t-tests were used to analyze and compare the antibiotic sensitivity trends over the study period.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>14,473 isolates recovered from 13,937 CSF samples of VP shunt infections were identified and analyzed for their susceptibility patterns to antimicrobials. The proportion of Gram-negative and Gram-positive bacteria were 11,030 (76%) and 3443 (24)%, respectively. The predominant bacteria were <jats:italic>Acinetobacter<\/jats:italic> species (<jats:italic>n<\/jats:italic>\u2009=\u20095898, 41%), followed by <jats:italic>Pseudomonas<\/jats:italic> species (<jats:italic>n<\/jats:italic>\u2009=\u20092368, 16%) and coagulase-negative <jats:italic>Staphylococcus<\/jats:italic> (CoNS) (<jats:italic>n<\/jats:italic>\u2009=\u20091880, 13%). 100% of <jats:italic>Staphylococcus aureus (S.aureus)<\/jats:italic> and CoNS were sensitive to vancomycin and linezolid (<jats:italic>n<\/jats:italic>\u2009=\u20092580). However, 52% of <jats:italic>S. aureus<\/jats:italic> (719\/1,343) were methicillin-resistant <jats:italic>Staphylococcus aureus<\/jats:italic> (MRSA). <jats:italic>Acinetobacter<\/jats:italic> showed maximum sensitivity to meropenem at 69% (2759\/4768). <jats:italic>Pseudomonas<\/jats:italic> was 80% (1385\/1863 sensitive to piperacillin-tazobactam, <jats:italic>Escherichia coli<\/jats:italic> (<jats:italic>E. coli)<\/jats:italic> showed 72% to amikacin (748\/1055), while <jats:italic>Klebsiella<\/jats:italic> spp. was 57% (574\/1170) sensitive to piperacillin-tazobactam. The sensitivity of piperacillin-tazobactam and meropenem for Gram-negative bacteria decreased significantly (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05) over 7 years, with 92.2% and 88.91% sensitive in 2015 and 66.7% and 62.8% sensitive in 2021, respectively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The significant decrease in the effectiveness of carbapenem and beta-lactam\/beta-lactamase inhibitor combination drugs for the common Gram-negative causative agents of VP shunt infections suggests that alternative antibiotics such as colistin, fosfomycin, ceftazidime\/avibactam, ceftolozane\/tazobactam, and tigecycline should be considered and in consequence included in testing panels. Additionally, it is recommended to adopt care bundles for the prevention of VP shunt infection.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13756-023-01283-3","type":"journal-article","created":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T05:01:42Z","timestamp":1691470902000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Bacterial ventriculoperitoneal shunt infections: changing trends in antimicrobial susceptibility, a 7-year retrospective study\u00a0from Pakistan"],"prefix":"10.1186","volume":"12","author":[{"given":"Amina","family":"Akram Asif","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Mahmood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saba","family":"Riaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"McHugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sikander","family":"Sultan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,8]]},"reference":[{"issue":"aop","key":"1283_CR1","first-page":"1","volume":"1","author":"S Muram","year":"2022","unstructured":"Muram S, et al. A standardized infection prevention bundle for reduction of CSF shunt infections in adult ventriculoperitoneal shunt surgery performed without antibiotic-impregnated catheters. J Neurosurg. 2022;1(aop):1\u20139.","journal-title":"J Neurosurg"},{"key":"1283_CR2","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.inat.2018.04.004","volume":"13","author":"M Paff","year":"2018","unstructured":"Paff M, et al. Ventriculoperitoneal shunt complications: a review. Interdiscip Neurosurg. 2018;13:66\u201370.","journal-title":"Interdiscip Neurosurg"},{"key":"1283_CR3","doi-asserted-by":"crossref","unstructured":"Ferras M., et al., Ventriculoperitoneal shunts in the emergency department: a review. Cureus 2020; 12(2).","DOI":"10.7759\/cureus.6857"},{"issue":"4","key":"1283_CR4","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.18203\/2349-2902.isj20171135","volume":"4","author":"RD Jaykar","year":"2017","unstructured":"Jaykar RD, Patil SP. Indications of ventriculoperitoneal shunt: a prospective study. Int Surg J. 2017;4(4):1319\u201326.","journal-title":"Int Surg J"},{"key":"1283_CR5","unstructured":"https:\/\/www.uptodate.com\/contents\/infections-of-cerebrospinal-fluid-shunts-and-other-devices"},{"issue":"4","key":"1283_CR6","doi-asserted-by":"publisher","first-page":"671","DOI":"10.4103\/0028-3886.185408","volume":"64","author":"V Kumar","year":"2016","unstructured":"Kumar V, et al. Ventriculoperitoneal shunt tube infection and changing pattern of antibiotic sensitivity in neurosurgery practice: alarming trends. Neurol India. 2016;64(4):671.","journal-title":"Neurol India"},{"issue":"7","key":"1283_CR7","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1086\/368191","volume":"36","author":"MJ McGirt","year":"2003","unstructured":"McGirt MJ, et al. Risk factors for pediatric ventriculoperitoneal shunt infection and predictors of infectious pathogens. Clin Infect Dis. 2003;36(7):858\u201362.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"1283_CR8","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3171\/jns.2001.94.2.0195","volume":"94","author":"AV Kulkarni","year":"2001","unstructured":"Kulkarni AV, Drake JM, Lamberti-Pasculli M. Cerebrospinal fluid shunt infection: a prospective study of risk factors. J Neurosurg. 2001;94(2):195\u2013201.","journal-title":"J Neurosurg"},{"key":"1283_CR9","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.wneu.2013.01.096","volume":"81","author":"G Reddy","year":"2014","unstructured":"Reddy G, Bollam P, Caldito G. Long-term outcomes of ventriculoperitoneal shunt surgery in patients with hydrocephalus. World Neurosurg. 2014;81:404\u201310.","journal-title":"World Neurosurg"},{"issue":"3","key":"1283_CR10","doi-asserted-by":"publisher","first-page":"e00253","DOI":"10.1128\/spectrum.00253-22","volume":"10","author":"Y Ye","year":"2022","unstructured":"Ye Y, et al. Carbapenem-resistant gram-negative bacteria-related healthcare-associated ventriculitis and meningitis: antimicrobial resistance of the pathogens, treatment, and outcome. Microbiol Spectr. 2022;10(3):e00253-e322.","journal-title":"Microbiol Spectr"},{"key":"1283_CR11","doi-asserted-by":"publisher","first-page":"697","DOI":"10.2147\/IDR.S326456","volume":"1","author":"M Karvouniaris","year":"2022","unstructured":"Karvouniaris M, et al. Current perspectives on the diagnosis and management of healthcare-associated ventriculitis and meningitis. Infect Drug Resistance. 2022;1:697\u2013721.","journal-title":"Infect Drug Resistance"},{"key":"1283_CR12","doi-asserted-by":"crossref","unstructured":"Elango D. General principles of antimicrobial therapy. Introduction to basics of pharmacology and toxicology: volume 2: essentials of systemic pharmacology: from principles to practice, 2021; p. 795\u2013806.","DOI":"10.1007\/978-981-33-6009-9_52"},{"key":"1283_CR13","unstructured":"Global laboratory standards for a healthier world."},{"issue":"3","key":"1283_CR14","doi-asserted-by":"publisher","first-page":"e00190","DOI":"10.1128\/CMR.00190-19","volume":"33","author":"R Nau","year":"2020","unstructured":"Nau R, Blei C, Eiffert H. Intrathecal antibacterial and antifungal therapies. Clin Microbiol Rev. 2020;33(3):e00190-e219.","journal-title":"Clin Microbiol Rev"},{"key":"1283_CR15","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s12028-018-0647-0","volume":"30","author":"JJ Lewin","year":"2019","unstructured":"Lewin JJ, et al. Current practices of intraventricular antibiotic therapy in the treatment of meningitis and ventriculitis: results from a multicenter retrospective cohort study. Neurocrit Care. 2019;30:609\u201316.","journal-title":"Neurocrit Care"},{"issue":"4","key":"1283_CR16","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S1684-1182(10)60047-3","volume":"43","author":"C-J Chang","year":"2010","unstructured":"Chang C-J, et al. Influence of third-generation cephalosporin resistance on adult in-hospital mortality from post-neurosurgical bacterial meningitis. J Microbiol Immunol Infect. 2010;43(4):301\u20139.","journal-title":"J Microbiol Immunol Infect"},{"issue":"1\u20132","key":"1283_CR17","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.wneu.2011.10.034","volume":"78","author":"GK Reddy","year":"2012","unstructured":"Reddy GK, Bollam P, Caldito G. Ventriculoperitoneal shunt surgery and the risk of shunt infection in patients with hydrocephalus: long-term single institution experience. World Neurosurg. 2012;78(1\u20132):155\u201363.","journal-title":"World Neurosurg"},{"key":"1283_CR18","unstructured":"Population welfare department; Government of Punjab, Pakistan. https:\/\/pwd.punjab.gov.pk\/population_profile."},{"key":"1283_CR19","unstructured":"Analysis and presentation of cumulative antimicrobial susceptibilty test data; approved guideline fourth edition. Clin Lab Standard Inst, 2014; A4(M39)."},{"key":"1283_CR20","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9780511581304","volume-title":"District laboratory practice in tropical countries, part 2","author":"M Cheesbrough","year":"2005","unstructured":"Cheesbrough M. District laboratory practice in tropical countries, part 2. Cambridge: Cambridge University Press; 2005."},{"issue":"1","key":"1283_CR21","doi-asserted-by":"publisher","first-page":"29","DOI":"10.4103\/jacm.jacm_8_19","volume":"21","author":"S Krishna","year":"2019","unstructured":"Krishna S, et al. Ten-year retrospective study on ventriculoperitoneal shunt infections from a university teaching hospital, South India. J Acad Clin Microbiol. 2019;21(1):29.","journal-title":"J Acad Clin Microbiol"},{"issue":"2","key":"1283_CR22","doi-asserted-by":"publisher","first-page":"195","DOI":"10.4103\/0028-3886.79136","volume":"59","author":"D Srinivas","year":"2011","unstructured":"Srinivas D, et al. The incidence of postoperative meningitis in neurosurgery: an institutional experience. Neurol India. 2011;59(2):195.","journal-title":"Neurol India"},{"key":"1283_CR23","unstructured":"Moore JE. Meningococcal disease section 3: diagnosis and management: MeningoNI forum. Ulster Med J 2018; 87(2): 94-98"},{"issue":"2","key":"1283_CR24","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3171\/2014.10.PEDS14178","volume":"15","author":"H Okechi","year":"2015","unstructured":"Okechi H, Ferson S, Albright AL. Bacteria causing ventriculoperitoneal shunt infections in a Kenyan population. J Neurosurg Pediatr. 2015;15(2):150\u20135.","journal-title":"J Neurosurg Pediatr"},{"key":"1283_CR25","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.wneu.2019.05.057","volume":"129","author":"T Zervos","year":"2019","unstructured":"Zervos T, Walters BC. Diagnosis of ventricular shunt infection in children: a systematic review. World Neurosurg. 2019;129:34\u201344.","journal-title":"World Neurosurg"},{"issue":"1","key":"1283_CR26","doi-asserted-by":"publisher","first-page":"7","DOI":"10.33713\/egetbd.668395","volume":"3","author":"S Yildizhan","year":"2020","unstructured":"Yildizhan S, Boyaci MG. Clinical effects of external ventricular drainage system, potential complications and complication management. Ege T\u0131p Bilimleri Dergisi. 2020;3(1):7\u201312.","journal-title":"Ege T\u0131p Bilimleri Dergisi"},{"key":"1283_CR27","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.wneu.2016.07.002","volume":"94","author":"AR Al-Schameri","year":"2016","unstructured":"Al-Schameri AR, et al. Ventriculoatrial shunts in adults, incidence of infection, and significant risk factors: a single-center experience. World Neurosurg. 2016;94:345\u201351.","journal-title":"World Neurosurg"},{"issue":"1","key":"1283_CR28","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jinf.2020.02.004","volume":"81","author":"KR Dorresteijn","year":"2020","unstructured":"Dorresteijn KR, et al. Cerebrospinal fluid analysis from bilateral external ventricular drains in suspected nosocomial infection. J Infect. 2020;81(1):147\u201378.","journal-title":"J Infect"},{"issue":"5","key":"1283_CR29","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.3171\/2014.8.JNS132557","volume":"122","author":"IS Kourbeti","year":"2015","unstructured":"Kourbeti IS, et al. Infections in patients undergoing craniotomy: risk factors associated with post-craniotomy meningitis. J Neurosurg. 2015;122(5):1113\u20139.","journal-title":"J Neurosurg"},{"key":"1283_CR30","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s15010-018-1234-1","volume":"47","author":"J Xiao","year":"2019","unstructured":"Xiao J, Zhang C, Ye S. Acinetobacter baumannii meningitis in children: a case series and literature review. Infection. 2019;47:643\u20139.","journal-title":"Infection"},{"issue":"2","key":"1283_CR31","doi-asserted-by":"publisher","first-page":"E8","DOI":"10.3171\/2019.5.FOCUS19278","volume":"47","author":"R Sharma","year":"2019","unstructured":"Sharma R, et al. Outcome following postneurosurgical Acinetobacter meningitis: an institutional experience of 72 cases. Neurosurg Focus. 2019;47(2):E8.","journal-title":"Neurosurg Focus"},{"issue":"1","key":"1283_CR32","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1086\/653120","volume":"51","author":"J Fishbain","year":"2010","unstructured":"Fishbain J, Peleg AY. Treatment of acinetobacter infections. Clin Infect Dis. 2010;51(1):79\u201384.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"1283_CR33","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.1093\/cid\/ciw861","volume":"64","author":"AR Tunkel","year":"2017","unstructured":"Tunkel AR, et al. 2017 infectious diseases society of America\u2019s clinical practice guidelines for healthcare-associated ventriculitis and meningitis. Clin Infect Dis. 2017;64(6):e34\u201365.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"1283_CR34","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3340\/jkns.2019.0219","volume":"64","author":"WX Zhou","year":"2021","unstructured":"Zhou WX, Hou WB, Zhou C, Yin YX, Lu ST, Liu G, Fang Y, Li JW, Wang Y, Liu AH, Zhang HJ. Systematic review and meta-analysis of antibiotic-impregnated shunt catheters on anti-infective effect of hydrocephalus shunt. J Korean Neurosurg Soc. 2021;64(2):297\u2013308. https:\/\/doi.org\/10.3340\/jkns.2019.0219.","journal-title":"J Korean Neurosurg Soc"},{"issue":"1","key":"1283_CR35","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3171\/2011.4.PEDS10551","volume":"8","author":"JR Kestle","year":"2011","unstructured":"Kestle JR, Riva-Cambrin J, Wellons JC, Kulkarni AV, Whitehead WE, Walker ML, Oakes WJ, Drake JM, Luerssen TG, Simon TD, Holubkov R. A standardized protocol to reduce cerebrospinal fluid shunt infection: the hydrocephalus clinical research network quality improvement initiative. J Neurosurg Pediatr. 2011;8(1):22\u20139.","journal-title":"J Neurosurg Pediatr"}],"container-title":["Antimicrobial Resistance &amp; Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-023-01283-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13756-023-01283-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-023-01283-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T21:39:44Z","timestamp":1700602784000},"score":1,"resource":{"primary":{"URL":"https:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-023-01283-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,8]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1283"],"URL":"https:\/\/doi.org\/10.1186\/s13756-023-01283-3","relation":{},"ISSN":["2047-2994"],"issn-type":[{"value":"2047-2994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,8]]},"assertion":[{"value":"16 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We carried out the study per the Declaration of Helsinki's Ethical Principles and Good Clinical Practices. Lahore General Hospital \/The Punjab Institute of Neurosciences, Lahore Institutional Ethics Committee approved the study (Ref. No. EC\/PINS\/RO No; 246-11).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"There is no conflicting personal or financial interest to be declared.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"75"}}